ASEJF yields 1.96% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 5
Combined, ASEJF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ASEJF + JNJ for your $10,000?
APT Satellite Holdings Limited, an investment holding company, maintains, operates, and provides satellite transponder capacity and related services, satellite-based broadcasting and telecommunications services, and other services. It offers a range of C-band and Ku-band transponder leasing services to its broadcast and telecommunication customers; satellite TV broadcasting and multi channel per carrier broadcast platforms services; and teleport and network services, including hub-based and single channel per carrier services. The company also provides data center services that comprise rack leasing, server and equipment hosting, cloud management, IP gateway transit, and customized managed services; offers OTT services. It operates in-orbit satellites consisting of APSTAR-5C, APSTAR-6C, APSTAR-7, and APSTAR-9 in Asia, Australia, the Middle East, Africa, Europe, and the Pacific region. In addition, the company engages in property holding activities; and the provision of management and project management consultancy services. The company was founded in 1992 and is headquartered in Tai Po, Hong Kong. APT Satellite Holdings Limited is a subsidiary of APT Satellite International Company Limited.
Full ASEJF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.